Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
American Journal of Clinical Oncology|June 1, 2002
Combination of vinorelbine, epirubicin, and cyclophosphamide as neoadjuvant chemotherapy for locally advanced breast cancer: phase II studyA C Braud, E Levy, F Feuilhade, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2005
Dealing with metastatic breast cancer in elderly women: results from a French study on a large cohort carried out by the 'Observatory on Elderly Patients'G Freyer, A-C Braud, P Chaibi, et al.
Anticancer Research|April 9, 2005
High-dose alkylating agents with autologous hematopoietic stem cell support and trastuzumab in ERBB2 overexpressing metastatic breast cancer: a feasibility studyA Gonçalves, A C Braud, F Viret, et al.
Anticancer Research|August 21, 2003
Phase I study of pegylated liposomal doxorubicin (Caelyx) in combination with carboplatin in patients with advanced solid tumorsA Gonçalves, A C Braud, F Viret, et al.
Annals of Surgical Oncology|July 14, 2004
Determinants of patients' choice of reconstruction with mastectomy for primary breast cancerP Ananian, G Houvenaeghel, C Protière, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysisP Thirion, S Michiels, J P Pignon, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 7, 2004
Patients' and surgeons' perspectives on axillary surgery for breast cancerS Arnaud, G Houvenaeghel, V Moutardier, et al.
Bone Marrow Transplantation|June 1, 2002
Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantationA C Braud, M P Mathoulin Portier, V J Bardou, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?A C Braud, B Asselain, S Scholl, et al.
Bone Marrow Transplantation|June 25, 2002
Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimensD Genre, P Viens, F Bertucci, et al.
Pageof 2